JP2020032088A - 遊技機 - Google Patents
遊技機 Download PDFInfo
- Publication number
- JP2020032088A JP2020032088A JP2018163293A JP2018163293A JP2020032088A JP 2020032088 A JP2020032088 A JP 2020032088A JP 2018163293 A JP2018163293 A JP 2018163293A JP 2018163293 A JP2018163293 A JP 2018163293A JP 2020032088 A JP2020032088 A JP 2020032088A
- Authority
- JP
- Japan
- Prior art keywords
- state
- combination
- stop operation
- game
- advantageous section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001613 Gambling Diseases 0.000 abstract description 47
- 230000001351 cycling effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 description 1199
- 230000008569 process Effects 0.000 description 1035
- 238000012545 processing Methods 0.000 description 844
- 230000000694 effects Effects 0.000 description 834
- 230000007704 transition Effects 0.000 description 613
- 238000003825 pressing Methods 0.000 description 449
- 238000003860 storage Methods 0.000 description 336
- 230000006870 function Effects 0.000 description 326
- 239000002243 precursor Substances 0.000 description 240
- 230000008901 benefit Effects 0.000 description 212
- 230000008859 change Effects 0.000 description 211
- 238000004891 communication Methods 0.000 description 189
- 230000001965 increasing effect Effects 0.000 description 156
- 102100026662 Delta and Notch-like epidermal growth factor-related receptor Human genes 0.000 description 153
- 230000005540 biological transmission Effects 0.000 description 110
- 241000219109 Citrullus Species 0.000 description 104
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 104
- 238000013500 data storage Methods 0.000 description 103
- 238000004364 calculation method Methods 0.000 description 98
- 238000003780 insertion Methods 0.000 description 89
- 238000007726 management method Methods 0.000 description 88
- 230000037431 insertion Effects 0.000 description 86
- 230000001276 controlling effect Effects 0.000 description 77
- 238000004519 manufacturing process Methods 0.000 description 76
- 210000001508 eye Anatomy 0.000 description 74
- 230000001976 improved effect Effects 0.000 description 74
- 230000007423 decrease Effects 0.000 description 72
- 238000012546 transfer Methods 0.000 description 72
- 238000012544 monitoring process Methods 0.000 description 71
- 238000002360 preparation method Methods 0.000 description 65
- 238000001994 activation Methods 0.000 description 61
- 230000004913 activation Effects 0.000 description 60
- 238000010586 diagram Methods 0.000 description 54
- YAFQFNOUYXZVPZ-UHFFFAOYSA-N liproxstatin-1 Chemical compound ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1 YAFQFNOUYXZVPZ-UHFFFAOYSA-N 0.000 description 41
- 238000012790 confirmation Methods 0.000 description 40
- 238000004904 shortening Methods 0.000 description 40
- 238000001514 detection method Methods 0.000 description 39
- 241000167854 Bourreria succulenta Species 0.000 description 36
- 235000019693 cherries Nutrition 0.000 description 36
- 230000003213 activating effect Effects 0.000 description 32
- 101150077696 lip-1 gene Proteins 0.000 description 32
- 238000012360 testing method Methods 0.000 description 28
- 238000009826 distribution Methods 0.000 description 26
- 244000208734 Pisonia aculeata Species 0.000 description 24
- 230000033228 biological regulation Effects 0.000 description 24
- 238000009795 derivation Methods 0.000 description 21
- 238000012986 modification Methods 0.000 description 21
- 230000004048 modification Effects 0.000 description 21
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 16
- 230000003111 delayed effect Effects 0.000 description 16
- 238000013461 design Methods 0.000 description 16
- 238000012423 maintenance Methods 0.000 description 16
- 230000007123 defense Effects 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 15
- 230000001747 exhibiting effect Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 230000004044 response Effects 0.000 description 14
- 230000003247 decreasing effect Effects 0.000 description 13
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 12
- 239000004973 liquid crystal related substance Substances 0.000 description 12
- 230000002349 favourable effect Effects 0.000 description 11
- 239000000758 substrate Substances 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 230000005281 excited state Effects 0.000 description 8
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 230000008450 motivation Effects 0.000 description 7
- 238000009877 rendering Methods 0.000 description 7
- 230000029087 digestion Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 230000001151 other effect Effects 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 101000746134 Homo sapiens DNA endonuclease RBBP8 Proteins 0.000 description 5
- 101000969031 Homo sapiens Nuclear protein 1 Proteins 0.000 description 5
- 102100021133 Nuclear protein 1 Human genes 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000007562 laser obscuration time method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 238000011410 subtraction method Methods 0.000 description 4
- 230000009747 swallowing Effects 0.000 description 4
- 101000726148 Homo sapiens Protein crumbs homolog 1 Proteins 0.000 description 3
- 102100027331 Protein crumbs homolog 1 Human genes 0.000 description 3
- 101000825534 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 40S ribosomal protein S2 Proteins 0.000 description 3
- 230000002844 continuous effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004397 blinking Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 230000005574 cross-species transmission Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000005401 electroluminescence Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002250 progressing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 101001080292 Homo sapiens Iron-sulfur cluster co-chaperone protein HscB Proteins 0.000 description 1
- 101000610557 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp31 Proteins 0.000 description 1
- 102100027530 Iron-sulfur cluster co-chaperone protein HscB Human genes 0.000 description 1
- 241000556720 Manga Species 0.000 description 1
- 101001109965 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L7-A Proteins 0.000 description 1
- 101001109960 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L7-B Proteins 0.000 description 1
- 102100040118 U4/U6 small nuclear ribonucleoprotein Prp31 Human genes 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013144 data compression Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Images
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018163293A JP2020032088A (ja) | 2018-08-31 | 2018-08-31 | 遊技機 |
| JP2022016041A JP7224072B2 (ja) | 2018-08-31 | 2022-02-04 | 遊技機 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018163293A JP2020032088A (ja) | 2018-08-31 | 2018-08-31 | 遊技機 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022016041A Division JP7224072B2 (ja) | 2018-08-31 | 2022-02-04 | 遊技機 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020032088A true JP2020032088A (ja) | 2020-03-05 |
| JP2020032088A5 JP2020032088A5 (enrdf_load_stackoverflow) | 2021-05-20 |
Family
ID=69666371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018163293A Pending JP2020032088A (ja) | 2018-08-31 | 2018-08-31 | 遊技機 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2020032088A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020032089A (ja) * | 2018-08-31 | 2020-03-05 | 株式会社ユニバーサルエンターテインメント | 遊技機 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017113396A (ja) * | 2015-12-25 | 2017-06-29 | 株式会社三共 | スロットマシン |
| JP2017205412A (ja) * | 2016-05-20 | 2017-11-24 | 株式会社オリンピア | 遊技機 |
| JP2017221423A (ja) * | 2016-06-15 | 2017-12-21 | 株式会社オリンピア | 遊技機 |
| JP2018042733A (ja) * | 2016-09-14 | 2018-03-22 | 株式会社三共 | スロットマシン |
| JP2018068509A (ja) * | 2016-10-26 | 2018-05-10 | サミー株式会社 | スロットマシン |
| JP6338309B1 (ja) * | 2017-09-12 | 2018-06-06 | 株式会社北電子 | 遊技機 |
| JP2018108263A (ja) * | 2016-12-31 | 2018-07-12 | 株式会社Ｂｏｏｏｍ | 遊技機 |
| JP2020010896A (ja) * | 2018-07-19 | 2020-01-23 | サミー株式会社 | 遊技機 |
-
2018
- 2018-08-31 JP JP2018163293A patent/JP2020032088A/ja active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017113396A (ja) * | 2015-12-25 | 2017-06-29 | 株式会社三共 | スロットマシン |
| JP2017205412A (ja) * | 2016-05-20 | 2017-11-24 | 株式会社オリンピア | 遊技機 |
| JP2017221423A (ja) * | 2016-06-15 | 2017-12-21 | 株式会社オリンピア | 遊技機 |
| JP2018042733A (ja) * | 2016-09-14 | 2018-03-22 | 株式会社三共 | スロットマシン |
| JP2018068509A (ja) * | 2016-10-26 | 2018-05-10 | サミー株式会社 | スロットマシン |
| JP2018108263A (ja) * | 2016-12-31 | 2018-07-12 | 株式会社Ｂｏｏｏｍ | 遊技機 |
| JP6338309B1 (ja) * | 2017-09-12 | 2018-06-06 | 株式会社北電子 | 遊技機 |
| JP2020010896A (ja) * | 2018-07-19 | 2020-01-23 | サミー株式会社 | 遊技機 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020032089A (ja) * | 2018-08-31 | 2020-03-05 | 株式会社ユニバーサルエンターテインメント | 遊技機 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020032101A (ja) | 遊技機 | |
| JP2020018756A (ja) | 遊技機 | |
| JP2020018746A (ja) | 遊技機 | |
| JP2020032097A (ja) | 遊技機 | |
| JP2020018761A (ja) | 遊技機 | |
| JP2020032083A (ja) | 遊技機 | |
| JP2020032089A (ja) | 遊技機 | |
| JP2020032088A (ja) | 遊技機 | |
| JP2020032091A (ja) | 遊技機 | |
| JP2020032090A (ja) | 遊技機 | |
| JP2020032095A (ja) | 遊技機 | |
| JP2020032093A (ja) | 遊技機 | |
| JP2020018752A (ja) | 遊技機 | |
| JP2020018763A (ja) | 遊技機 | |
| JP2020018748A (ja) | 遊技機 | |
| JP2020018751A (ja) | 遊技機 | |
| JP2020018639A (ja) | 遊技機 | |
| JP2020032092A (ja) | 遊技機 | |
| JP2020032085A (ja) | 遊技機 | |
| JP2020032084A (ja) | 遊技機 | |
| JP2020032086A (ja) | 遊技機 | |
| JP2020032098A (ja) | 遊技機 | |
| JP2020032100A (ja) | 遊技機 | |
| JP2020032087A (ja) | 遊技機 | |
| JP2020032094A (ja) | 遊技機 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210406 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210817 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210818 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211018 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20211109 |